Ticker
LSTACompany Name
LISATA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -1.35% | $ 24.52M | $ 330K |
3/31/2025 | -1.41% | $ 20.42M | $ 288K |
12/31/2024 | -0.33% | $ 20.69M | $ 68K |
9/30/2024 | -0.23% | $ 24.43M | $ 56K |
6/30/2024 | -0.23% | $ 24.37M | $ 56K |
3/31/2024 | -1.97% | $ 24.2M | $ 476K |
12/31/2023 | -1.96% | $ 24.34M | $ 476K |
9/30/2023 | -2.63% | $ 17.74M | $ 466K |
6/30/2023 | -2.12% | $ 21.98M | $ 466K |
3/31/2023 | -0.16% | $ 26.08M | $ 43K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for LISATA THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 18.99M ]) / Market Cap [ $ 31.23M ]
(=) Buyback Yield [ -60.81% ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.71% |